The Impact of Bisphosphonates on Bone Loss in Patients Undergoing Surgery and Postoperative Chemotherapy for Gynecologic Malignancies.
Phase of Trial: Phase II
Latest Information Update: 28 Jun 2011
At a glance
- Drugs Alendronic acid/colecalciferol (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 28 Jun 2011 Planned end date changed from 1 Feb 2010 to 1 Jun 2011 as reported by ClinicalTrials.gov.
- 28 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Mar 2009 New trial record